Weight loss maintenance following an augmented intervention for early slow weight loss responders: An adaptive trial
Translational Behavioral Medicine · 2024
DOI: 10.1093/tbm/ibad077 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Translational Behavioral Medicine, 2024. Verfasst von Carla K Miller und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health-Bloomington, Department of Applied Health Science, Indiana University, Bloomington, IN, USA. Hauptthemen laut MEDLINE: Weight Loss, Obesity, Prediabetic State, Overweight. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCATS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Early slow weight loss during treatment is associated with less weight loss overall. The impact of an augmented intervention designed for early slow weight loss responders compared with a standard diabetes prevention intervention was evaluated following 12 months of treatment and 6 months of no contact. The impact of standard vs. augmented intervention sequences on weight and glycemia also was determined. Adults were ≥21 years old with overweight or obesity and prediabetes (n = 174). Slow responders were stratified to augmented treatment if they failed to achieve >2.5% weight loss (%WL) at Week 5. Matched within-sex pairs of participants were created based on %WL at Month 5 following the intensive intervention phase, and each person within the pair was randomly assigned to treatment for Months 5–12 during the extended intervention phase. Both 12-month interventions included a ≥7%WL goal. Mean 12-month %WL was 5.29% (95% CI: 4.27%–6.31%; P < .0001) and 18-month %WL was 3.34% (95% CI: 2.01%–4.66%; P < .0001) overall. %WL was greater for the standard (9.55%) than the augmented (4.0%) intervention (P = .0001); no differences occurred in weight regain between early and slow responders (P = .9476). No differences occurred in mean %WL at 12 months between the standard and augmented groups after controlling for %WL at Week 5 and sex (P = .23) nor in the change in glycemia (all P > .05). WL following the first month of treatment predicted 12- and 18-month WL success regardless of intervention sequence; however, even early slow responders achieved significant WL during treatment. Further research is needed to support effective WL maintenance for people with prediabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health-Bloomington, Department of Applied Health Science, Indiana University, Bloomington, IN, USA.
- Division of Biostatistics, School of Public Health, Ohio State University, Columbus, OH, USA.
- Department of Psychology, Ohio State University, Columbus, OH, USA.
- Department of Human Sciences, Ohio State University, Columbus, OH, USA.
ORCID-Profile: Carla K Miller
Förderung
- NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- National Center for Advancing Translational Sciences
Zitieren
APA
Miller, C. K., Nagaraja, H. N., Fujita, K., Cheavens, J. S., & Focht, B. C. (2024). Weight loss maintenance following an augmented intervention for early slow weight loss responders: An adaptive trial. Translational Behavioral Medicine. https://doi.org/10.1093/tbm/ibad077
Vancouver
Miller CK, Nagaraja HN, Fujita K, Cheavens JS, Focht BC. Weight loss maintenance following an augmented intervention for early slow weight loss responders: An adaptive trial. Translational Behavioral Medicine. 2024. doi:10.1093/tbm/ibad077
BibTeX
@article{Miller2024,
author = {Miller, Carla K and Nagaraja, Haikady N and Fujita, Kentaro and Cheavens, Jennifer S and Focht, Brian C},
title = {Weight loss maintenance following an augmented intervention for early slow weight loss responders: An adaptive trial},
journal = {Translational Behavioral Medicine},
year = {2024},
doi = {10.1093/tbm/ibad077}
}
EUVIMED